67648-64-0

Basic information

• Product Name: 2-(4-hydroxyphenoxy)-2-methylpropionic acid
• Synonyms: 2-(4-hydroxyphenoxy)-2-Methyl-;2-(4-hydroxyphenoxy)-2-methylpropionic acid;2-(4-Hydroxyphenoxy)-2-methylpropanoic acid;AMCMPYSRJBOXBL-UHFFFAOYSA-N
• CAS NO: 67648-64-0
• Molecular Formula: C₁₀H₁₂O₄
• Molecular Weight: 196.1999
• Mol File: 67648-64-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 367°Cat760mmHg
• Flash Point: 146.8°C
• Appearance: /
• Density: 1.257g/cm³
• Vapor Pressure: 4.94E-06mmHg at 25°C
• Refractive Index: 1.557
• CAS DataBase Reference: 2-(4-hydroxyphenoxy)-2-methylpropionic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-hydroxyphenoxy)-2-methylpropionic acid(67648-64-0)
• EPA Substance Registry System: 2-(4-hydroxyphenoxy)-2-methylpropionic acid(67648-64-0)

Safety Data

• Hazardous Substances Data: 67648-64-0(Hazardous Substances Data)

Usage

Type of drug

Nonsteroidal anti-inflammatory drug (NSAID)

Primary uses

Analgesic, anti-inflammatory, and antipyretic medication

Mechanism of action

Inhibits the production of prostaglandins responsible for pain and inflammation

Conditions treated

Headaches, muscle aches, arthritis, menstrual cramps, and minor injuries

Availability

Over-the-counter and prescription forms

Safety

Generally considered safe when used as directed

Side effects

Can cause side effects and interactions with other medications

InChI:InChI=1/C10H12O4/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6,11H,1-2H3,(H,12,13)

Upstream product

• 2589-57-3 dimethyl 2,2'-azobis(isobutyrate) 
• 106-51-4 p-benzoquinone 
• 71-43-2 benzene 
• 123-31-9 hydroquinone 
• 882-09-7 Clofibric acid 
• 42806-90-6 2-(4-hydroxyphenoxy)-2-methyl propionic acid ethyl ester 
• 65727-21-1 α-(4-hydroxy-phenoxy)-isobutyronitrile 

Relevant articles and documents

FeOOH and derived phases: Efficient heterogeneous catalysts for clofibric acid degradation by advanced oxidation processes (AOPs)

In this study the degradation of an aqueous solution of clofibric acid was investigated during catalytic ozonation and Fenton-like process with FeOOH - derived catalysts. From the different calcination temperatures tested, it has been observed that the most active catalyst is the commercial FeOOH calcined at 200°C, when maghemite and hematite are the predominant phases obtained. The best result, at room temperature, for CFA mineralization was observed over 0.5 wt% Pd on FeOOH (calcined at 200°C) among all tested catalysts, achieving 68% and 81% mineralization degree, in 2 h and 6 h, respectively, in catalytic ozonation and 66% and 71% of mineralization degree within 2 h and 6 h, respectively for Fenton process. The efficiency of the Fenton-like process is enhanced at higher temperature (40-60°C), reaching a mineralization degree up to 82% in 6 h. Furthermore, Pd impregnation on FeOOH increased the catalyst stability.